Category: Omicron VoC

JSON
CSV
XLSX
TXT

Primary: Shown in the list of current labels.

Year 2025

PubMed DOI Crossref
A meta-analysis on the immunogenicity of prototype, monovalent-adapted and bivalent vaccines against SARS-CoV-2 wildtype, Omicron BA.1 and Omicron BA.4/5 in healthy adults.
Banga Ndzouboukou J, Kamara AA, Ullah N, Lei Q, Fan X
Virology 606 (-) 110509 [2025-05-00; online 2025-03-19]
Category: Omicron VoC Type: Journal article
PubMed DOI Crossref
Distinct Omicron longitudinal memory T cell profile and T cell receptor repertoire associated with COVID-19 hospitalisation.
Markey G, McLaughlin J, McDaid D, ..., Shukla P, Gibson DS
Front Immunol 16 (-) 1549570 [2025-04-02; online 2025-04-02]
Category: Omicron VoC Category: Proteins Type: Journal article
PubMed DOI Crossref
Anti-viral action against type 1 diabetes autoimmunity: The GPPAD-AVAnT1A study protocol.
Hummel S, Käßl A, Arnolds S, ..., Bonifacio E, GPPAD Study Group
Contemp Clin Trials Commun 44 (-) 101434 [2025-04-00; online 2025-01-20]
Category: Health Category: Omicron VoC Type: Journal article
PubMed DOI Crossref
Variant-Specific Interactions at the Plasma Membrane: Heparan Sulfate's Impact on SARS-CoV-2 Binding Kinetics.
Conca DV, Bano F, Graul M, ..., Dahlin A, Bally M
Anal Chem 97 (8) 4318-4328 [2025-03-04; online 2025-02-20]
Category: Omicron VoC Category: Proteins Funder: H2020 Funder: KAW/SciLifeLab National COVID program Funder: VR Type: Journal article
PubMed DOI Crossref
A Meta-Analysis on the Immunogenicity of Homologous versus Heterologous Immunization Regimens against SARS-CoV-2 Beta, Delta, and Omicron BA.1 VoCs in Healthy Adults.
Ndzouboukou JB, Kamara AA, Ullah N, Lei Q, Fan X
J Microbiol Biotechnol 35 (-) e2411059 [2025-02-24; online 2025-02-24]
Category: Omicron VoC Category: Vaccines Type: Journal article
PubMed DOI Crossref
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: Focus on the very early period and Omicron era.
Hedberg P, Blixt L, Eketorp Sylvan S, ..., Osterborg A, Hansson L
Blood Adv - (-) - [2025-02-21; online 2025-02-21]
Category: Health Category: Omicron VoC Category: Serology Category: Vaccines Type: Journal article
PubMed DOI Crossref
60-day mortality and the role of SARS-CoV-2 in hospital admissions of immunocompromised patients during later Omicron period: a population-based study in Sweden.
Spreco A, Andersson C, Sjödahl R, Niward K
Infect Dis (Lond) - (-) 1-13 [2025-02-16; online 2025-02-16]
Category: Omicron VoC Category: Post-COVID Funder: Hjärt-Lungfonden Funder: VR Type: Journal article
PubMed DOI Crossref
Comparison of Airborne SARS-CoV-2 Omicron and Pre-Delta Variants Around Infected Patients.
Fraenkel C, Thuresson S, Medstrand P, Alsved M, Löndahl J
J Med Virol 97 (2) e70258 [2025-02-00; online 2025-02-20]
Category: Health Category: Omicron VoC Funder: VR Type: Journal article

Year 2024

PubMed DOI Crossref
Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors after allogeneic hematopoietic stem cell transplantation.
Einarsdottir S, Al-Dury S, Fridriksson E, ..., Waldenström J, Lagging M
Sci Rep 14 (1) 24749 [2024-10-21; online 2024-10-21]
Category: Omicron VoC Category: Vaccines Type: Journal article
PubMed DOI Crossref
Risk of COVID-19 hospitalisation by HIV-status and SARS-CoV-2 vaccination status during pre- and post-Omicron era in a national register-based cohort study in Sweden.
Killander Möller I, Hedberg P, Wagner P, ..., Aleman S, Carlander C
Infect Dis (Lond) - (-) 1-14 [2024-09-25; online 2024-09-25]
Category: Health Category: Omicron VoC Category: Post-COVID Category: Vaccines Funder: KAW/SciLifeLab National COVID program Funder: VR Type: Journal article
PubMed DOI Crossref
The Omicron Variant Is Associated with a Reduced Risk of the Post COVID-19 Condition and Its Main Phenotypes Compared to the Wild-Type Virus: Results from the EuCARE-POSTCOVID-19 Study.
Bai F, Santoro A, Hedberg P, ..., Marchetti G, EuCARE Project
Viruses 16 (9) - [2024-09-23; online 2024-09-23]
Category: Genomics & transcriptomics Category: Omicron VoC Category: Post-COVID Funder: H2020 Type: Journal article
PubMed DOI Crossref
Differential immunometabolic responses to Delta and Omicron SARS-CoV-2 variants in golden syrian hamsters.
Rajaiah R, Pandey K, Acharya A, ..., Neogi U, Byrareddy SN
iScience 27 (8) 110501 [2024-08-16; online 2024-07-14]
Category: Health Category: Omicron VoC Funder: VR Type: Journal article
PubMed DOI Crossref
Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutations.
Selvavinayagam ST, Sankar S, Yong YK, ..., Shankar EM, Raju S
Sci Rep 14 (1) 17476 [2024-07-30; online 2024-07-30]
Category: Omicron VoC Funder: VR Type: Journal article
PubMed DOI Crossref
Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques.
Mandolesi M, Das H, de Vries L, ..., Murrell B, Karlsson Hedestam GB
Nat Commun 15 (1) 6338 [2024-07-27; online 2024-07-27]
Category: Omicron VoC Category: Vaccines Funder: SciLifeLab PLP program Funder: VR Type: Journal article
PubMed DOI Crossref
Severity outcomes of SARS-CoV-2 infection in the Omicron and pre-Omicron periods, in unvaccinated first-time test positive adults less than 65 years old without comorbidity, in Sweden.
Wahlström E, Bruce D, Bennet-Bark AM, ..., Hanberger H, Strålin K
J Infect Public Health 17 (9) 102502 [2024-07-23; online 2024-07-23]
Category: Omicron VoC Category: Vaccines Type: Journal article
PubMed DOI Crossref
The impact of the COVID-19 vaccination programme on symptomatic and severe SARS-CoV-2 infection during a period of Omicron variant dominance in Ireland, December 2021 to March 2023.
Marron L, Mateo-Urdiales A, O'Donnell J, Robinson E, Domegan L
Euro Surveill 29 (28) - [2024-07-00; online 2024-07-12]
Category: Omicron VoC Category: Vaccines Type: Journal article
PubMed DOI Crossref
Effectiveness against severe COVID-19 of a seasonal booster dose of bivalent (original/Omicron BA.4-5) mRNA vaccines in persons aged ≥60 years: Estimates over calendar time and by time since administration during prevalent circulation of different Omicron subvariants, Italy, 2022-2023.
Fabiani M, Mateo-Urdiales A, Sacco C, ..., Pezzotti P, Italian Integrated Surveillance of COVID-19 study group and of the Italian COVID-19 Vaccines Registry group
Vaccine - (-) - [2024-06-03; online 2024-06-03]
Category: Omicron VoC Category: Vaccines Type: Journal article
PubMed DOI Crossref
Association of pre-existing depression and anxiety with Omicron variant infection.
Yang H, Yang L, Chen W, ..., Li Q, Song H
Mol Psychiatry - (-) - [2024-05-16; online 2024-05-16]
Category: Omicron VoC Category: Social Science & Humanities Type: Journal article
PubMed DOI Crossref
Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies.
Sheward DJ, Pushparaj P, Das H, ..., Karlsson Hedestam GB, Hällberg BM
Cell Rep Med - (-) 101577 [2024-05-15; online 2024-05-15]
Category: Genomics & transcriptomics Category: Omicron VoC Category: Proteins Funder: KAW/SciLifeLab National COVID program Funder: VR Type: Journal article
PubMed DOI Crossref
Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study.
Moustsen-Helms IR, Bager P, Larsen TG, ..., Hansen CH, SSI-DMC Study Group
Lancet Infect Dis - (-) - [2024-05-15; online 2024-05-15]
Category: Omicron VoC Category: Vaccines Type: Journal article
PubMed DOI Crossref
Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Mortality: A Systematic Literature Review.
Cha-Silva AS, Gavaghan MB, Bergroth T, ..., McLaughlin JM, Nguyen JL
Am J Ther 31 (3) e246-e257 [2024-04-29; online 2024-04-29]
Category: Health Category: Omicron VoC Type: Review
PubMed DOI Crossref
Previous SARS-CoV-2 infections and their impact on the protection from reinfection during the Omicron BA.5 wave - a nested case-control study among vaccinated adults in Sweden.
Kahn F, Bonander C, Moghaddassi M, ..., Inghammar M, Björk J
IJID Reg 10 (-) 235-239 [2024-03-00; online 2024-02-28]
Category: Health Category: Omicron VoC Funder: Forte Funder: VR Funder: Vinnova Type: Journal article
PubMed DOI Crossref
Genomic surveillance of omicron B.1.1.529 SARS-CoV-2 and its variants between December 2021 and March 2023 in Tamil Nadu, India-A state-wide prospective longitudinal study.
Selvavinayagam ST, Suvaithenamudhan S, Yong YK, ..., Shankar EM, Raju S
J Med Virol 96 (2) e29456 [2024-02-00; online 2024-02-08]
Category: Genomics & transcriptomics Category: Omicron VoC Funder: VR Funder: Vinnova Type: Journal article

Year 2023

PubMed DOI Crossref
Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study.
Evans RA, Dube S, Lu Y, ..., Taylor S, Quint JK
Lancet Reg Health Eur 35 (-) 100747 [2023-12-00; online 2023-10-13]
Category: Health Category: Omicron VoC Type: Journal article

Year 2022

PubMed DOI Crossref
Effectiveness of COVID-19 Vaccines over 13 Months Covering the Period of the Emergence of the Omicron Variant in the Swedish Population.
Xu Y, Li H, Kirui B, ..., Vanfleteren LEGW, Nyberg F
Vaccines 10 (12) - [2022-12-05; online 2022-12-05]
Category: Health Category: Omicron VoC Category: Vaccines Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Vaccine Topics: Register-based research Type: Journal article
PubMed DOI Crossref
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection.
Havervall S, Marking U, Svensson J, ..., Smed-Sörensen A, Thålin C
N Engl J Med 387 (14) 1333-1336 [2022-10-06; online 2022-09-14]
Category: Biochemistry Category: Health Category: Omicron VoC Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Type: Journal article
PubMed DOI Crossref
Monitoring of the SARS-CoV-2 Omicron BA.1/BA.2 lineage transition in the Swedish population reveals increased viral RNA levels in BA.2 cases.
Lentini A, Pereira A, Winqvist O, Reinius B
Med (N Y) 3 (9) 636-643.e4 [2022-09-09; online 2022-08-08]
Category: Biochemistry Category: Health Category: Omicron VoC Type: Journal article
PubMed DOI Crossref
Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in Norway.
Stålcrantz J, Kristoffersen AB, Bøås H, ..., Buanes EA, Whittaker R
Scand J Public Health 50 (6) 676-682 [2022-08-00; online 2022-07-07]
Category: Health Category: Omicron VoC Type: Journal article
PubMed DOI Crossref
Differences between Omicron SARS-CoV-2 RBD and other variants in their ability to interact with cell receptors and monoclonal antibodies.
Giron CC, Laaksonen A, Barroso da Silva FL
J Biomol Struct Dyn - (-) 1-21 [2022-07-09; online 2022-07-09]
Category: Biochemistry Category: Health Category: Omicron VoC Type: Journal article
PubMed DOI Crossref
Acute odynophagia: A new symptom of COVID-19 during the SARS-CoV-2 Omicron variant wave in Sweden.
Piersiala K, Kakabas L, Bruckova A, Starkhammar M, Cardell LO
J Intern Med 292 (1) 154-161 [2022-07-00; online 2022-03-06]
Category: Biochemistry Category: Health Category: Omicron VoC Type: Journal article
PubMed DOI Crossref
Hospital bed occupancy for COVID-19 or with SARS-CoV-2 infection in a Swedish county during the omicron wave.
Spreco A, Andersson C, Sjödahl R, Dahlström Ö, Timpka T
Influenza Other Respir Viruses - (-) - [2022-06-05; online 2022-06-05]
Category: Health Category: Omicron VoC Type: Journal article
PubMed DOI Crossref
SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022.
Sievers C, Zacher B, Ullrich A, ..., An der Heiden M, Kröger S
Euro Surveill 27 (22) - [2022-06-00; online 2022-06-04]
Category: Genomics & transcriptomics Category: Health Category: Omicron VoC Type: Journal article
PubMed DOI Crossref
Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study.
Sheward DJ, Kim C, Ehling RA, ..., Albert J, Murrell B
Lancet Infect Dis 22 (6) 813-820 [2022-06-00; online 2022-03-17]
Category: Biochemistry Category: Health Category: Omicron VoC Type: Journal article
PubMed DOI Crossref
Complex Mutation Pattern of Omicron BA.2: Evading Antibodies without Losing Receptor Interactions.
Kannan SR, Spratt AN, Sharma K, ..., Byrareddy SN, Singh K
Int J Mol Sci 23 (10) - [2022-05-16; online 2022-05-16]
Category: Biochemistry Category: Health Category: Omicron VoC Type: Journal article
PubMed DOI Crossref
Convulsions in children with COVID-19 during the Omicron wave.
Ludvigsson JF
Acta Paediatr 111 (5) 1023-1026 [2022-05-00; online 2022-02-10]
Category: Health Category: Omicron VoC Type: Journal article
PubMed DOI Crossref
Selection analysis identifies clusters of unusual mutational changes in Omicron lineage BA.1 that likely impact Spike function.
Martin DP, Lytras S, Lucaci AG, ..., de Oliveira T, Kosakovsky Pond SL
Mol Biol Evol - (-) - [2022-03-24; online 2022-03-24]
Category: Biochemistry Category: Health Category: Omicron VoC Category: Public Health Type: Journal article
PubMed DOI Crossref
Improved Binding Affinity of Omicron's Spike Protein for the Human Angiotensin-Converting Enzyme 2 Receptor Is the Key behind Its Increased Virulence.
Kumar R, Murugan NA, Srivastava V
Int J Mol Sci 23 (6) - [2022-03-21; online 2022-03-21]
Category: Biochemistry Category: Health Category: Omicron VoC Category: Public Health Type: Journal article
PubMed DOI Crossref
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
Schubert M, Bertoglio F, Steinke S, ..., Čičin-Šain L, Hust M
BMC Med 20 (1) 102 [2022-03-03; online 2022-03-03]
Category: Biochemistry Category: Health Category: Omicron VoC Type: Journal article
PubMed DOI Crossref
Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities - surveillance results from southern Sweden, July 2021 to January 2022.
Kahn F, Bonander C, Moghaddassi M, ..., Inghammar M, Björk J
Euro Surveill 27 (9) - [2022-03-00; online 2022-03-05]
Category: Health Category: Omicron VoC Type: Journal article
DOI Crossref
Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a cohort study
Staessen JA, Wendt R, Yu YL, ..., Mischak H, Beige J
medRxiv - (-) - [2022-01-23; online 2022-01-23]
Category: Biochemistry Category: Health Category: Omicron VoC Type: Preprint
DOI Crossref
Novel universal SARS-CoV DNA vaccine inducing neutralizing antibodies to huCoV-19/WH01, Beta, Delta and Omicron variants and T cells to Bat-CoV
Appelberg KS, Ahlen G, Nikoyan N, ..., mirazimi a, Sallberg M
Research Square - (-) - [2022-01-20; online 2022-01-20]
Category: Biochemistry Category: Drug Discovery Category: Health Category: Omicron VoC Category: Vaccines Type: Preprint
PubMed DOI Crossref
Selection analysis identifies unusual clustered mutational changes in Omicron lineage BA.1 that likely impact Spike function.
Martin DP, Lytras S, Lucaci AG, ..., de Oliveira T, Kosakovsky Pond SL
bioRxiv - (-) - [2022-01-18; online 2022-01-18]
Category: Biochemistry Category: Health Category: Omicron VoC Type: Preprint
DOI Crossref
Towards an optimal monoclonal antibody with higher binding affinity to the receptor-binding domain of SARS-CoV-2 spike proteins from different variants
Neamtu A, Mocci F, Laaksonen A, Barroso da Silva FL
bioRxiv - (-) - [2022-01-05; online 2022-01-05]
Category: Omicron VoC Type: Preprint
DOI Crossref
Heterologous immunization with inactivated vaccine followed by mRNA booster elicits strong humoral and cellular immune responses against the SARS-CoV-2 Omicron variant
Zuo F, Abolhassani H, Du L, ..., Marcotte H, Pan-Hammarström Q
medRxiv - (-) - [2022-01-05; online 2022-01-05]
Category: Biochemistry Category: Health Category: Omicron VoC Type: Preprint
DOI Crossref
Structural basis of Omicron neutralization by affinity-matured public antibodies
Sheward DJ, Pushparaj P, Das H, ..., Karlsson Hedestam GB, Hällberg BM
bioRxiv - (-) - [2022-01-04; online 2022-01-04]
Category: Biochemistry Category: Health Category: Omicron VoC Type: Preprint
PubMed DOI Crossref
Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022.
Veneti L, Bøås H, Bråthen Kristoffersen A, ..., Buanes EA, Whittaker R
Euro Surveill 27 (4) - [2022-01-00; online 2022-01-29]
Category: Health Category: Omicron VoC Type: Journal article

Year 2021

DOI Crossref
Influenza A H1N1–mediated pre-existing immunity to SARS-CoV-2 predicts COVID-19 outbreak dynamics
Almazán NM, Rahbar A, Carlsson M, ..., Sörensen B, Söderberg-Nauclér C
medRxiv - (-) - [2021-12-25; online 2021-12-25]
Category: Genomics & transcriptomics Category: Health Category: Omicron VoC Funder: KAW/SciLifeLab National COVID program Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Type: Preprint
PubMed DOI Crossref
Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies.
Kannan SR, Spratt AN, Sharma K, ..., Byrareddy SN, Singh K
J Autoimmun 126 (-) 102779 [2021-12-13; online 2021-12-13]
Category: Biochemistry Category: Health Category: Omicron VoC Type: Journal article
SciLifeLab Data Centre
Publications 9.5.1